The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; none of the 29 sources its claims cite is checked for support yet.
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
Open accessAbstract
Two Krebs cycle genes, fumarate hydratase ( FH ) and succinate dehydrogenase ( SDH ), are mutated in a subset of human cancers, leading to accumulation of their substrates, fumarate and succinate, respectively. Here we demonstrate that fumarate and succinate are competitive inhibitors of multiple α-ketoglutarate (α-KG)-dependent dioxygenases, including histone demethylases, prolyl hydroxylases, collagen prolyl-4-hydroxylases, and the TET (ten-eleven translocation) family of 5-methlycytosine (5mC) hydroxylases. Knockdown of FH and SDH results in elevated intracellular levels of fumarate and succinate, respectively, which act as competitors of α-KG to broadly inhibit the activity of α-KG-dependent dioxygenases. In addition, ectopic expression of tumor-derived FH and SDH mutants inhibits histone demethylation and hydroxylation of 5mC. Our study suggests that tumor-derived FH and SDH mutations accumulate fumarate and succinate, leading to enzymatic inhibition of multiple α-KG-dependent dioxygenases and consequent alterations of genome-wide histone and DNA methylation. These epigenetic alterations associated with mutations of FH and SDH likely contribute to tumorigenesis.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Fumarate and succinate, which accumulate when FH or SDH is lost, act as α-KG competitors and suppress multiple α-KG-dependent dioxygenases, including histone demethylases and TET DNA hydroxylases. This connects FH/SDH mutations to broad histone and DNA methylation changes that may contribute to tumorigenesis.
Key findings
- In vitro, fumarate and succinate inhibited CeKDM7A by more than 80% at 1–10 mM; for HsKDM4A, fumarate caused 22%, 41%, and 73% inhibition and succinate caused 43%, 68%, and 85% inhibition at 1, 3, and 10 mM, with succinate more potent (IC50 0.8 mM) than fumarate (IC50 1.5 mM).
- In cultured cells, cell-permeable fumarate or succinate increased H3K4 monomethylation about fourfold, H3K27 and H3K79 dimethylation about fourfold and threefold, and H3K4 trimethylation about twofold; FH or SDHA/B knockdown increased histone methylation three- to fivefold, raised HIF1α about fivefold, and lowered endostatin about sevenfold, effects diminished by cell-permeable α-KG.
- TET-catalyzed 5hmC production was reduced in FH, SDHA, or SDHB knockdown cells by 71%, 73%, and 82% for TET1 and by 80%, 83%, and 69% for TET2; in mouse liver, Fh or Sdha knockdown reduced 5hmC by 72% and 63% and increased Hoxa gene expression more than tenfold.
- Tumor-derived mutants were impaired: FH R190H and H137R retained 17% and 10% of wild-type activity; SDHA G555E and R554W retained 51% and 46%; SDHB R46Q and A43P retained 48% and 61%; wild-type but not mutant re-expression restored demethylation and 5hmC and reduced fumarate/succinate.
Methods
- In vitro demethylase assays used synthetic H3K9me1 and H3K36me3 peptides with MALDI-TOF/TOF mass spectrometry; FH and SDH enzyme activities were measured by absorbance-based assays.
- Cell work used HeLa and HEK293T cells with siRNA or stable knockdown of FH, SDHA, or SDHB, treatment with cell-permeable fumarate/succinate or octyl-α-KG, and TET1/TET2 catalytic-domain expression; readouts included GC-MS, Western blot, immunofluorescence, dot blot, and quantitative RT-PCR.
- In vivo work used hydrodynamic tail-vein siRNA delivery to knock down mouse liver Fh or Sdha (n = 3 per group); statistics used two-tailed unpaired Student’s t-test, triplicate experiments, and P < 0.05.
Limitations
- The paper notes an alternative product-inhibition model, observes that the succinate/α-KG ratio did not change in cells expressing tumor-derived FH mutants, and states that FH/SDH tumorigenesis may involve mechanisms independent of α-KG-dependent dioxygenases; it also says fumarate-mediated KEAP1 succination and NRF2 signaling require further exploration.
- The corrigendum reports that Figure 2B mislabeled SDHA and SDHB as FH and duplicated an actin control, though the authors state this does not affect the conclusions.
- Evident from the text: TET inhibition is inferred mainly from 5hmC readouts rather than direct TET enzyme kinetics, and the study relies on knockdown/overexpression and cell-permeable metabolite esters rather than direct human tumor metabolite-epigenome correlations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 29 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Here we demonstrate that fumarate and succinate are competitive inhibitors of multiple a-ketoglutarate (a-KG)dependent dioxygenases, including histone demethylases, prolyl hydroxylases, collagen prolyl-4-hydroxylases, and the TET (ten-eleven translocation) family of 5-methlycytosine (5mC) hydroxylases.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ectopic expression of tumor-derived FH and SDH mutants inhibits histone demethylation and hydroxylation of 5mC.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Fumarate and succinate inhibit the demethylase activity of human KDM4A (HsKDM4A) toward trimethylated H3K36, determined by mass spectrometry (MS) assay as in B.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cotransfection with wild-type FH, SDHA, or SDHB, but not their mutants (i.e., FH R190H , SDHA G555E , or SDHB R46Q ), could rescue the reduction of 5hmC levels in FH or SDH stable knockdown cells”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Knocking down FH or SDH reduces the TET-catalyzed 5hmC production in cultured cells.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cell-permeable fumarate (2.5 mM) or succinate (5 mM) increases histone methylation and HIF1a and reduces endostatin in HEK293T cells (left) and HeLa cells (right), as determined by Western-blot.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cell-permeable octyl-a-KG (5mM) diminishes the effect of FH or SDH suppression on increasing histone methylations, accumulating HIF1a, and decreasing endostatin in HEK293T cells with knockdown of FH (left panel), SDHA (middle panel), and SDHB (right panel), as determined by Western blot.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Succinate is more potent to inhibit HsKDM4A than fumarate.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 30
- The quote only partly states this claim. 6
- Probably not a substantial claim. 6
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Knockdown of FH and SDH results in elevated intracellular levels of fumarate and succinate, respectively”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Knockdown of FH, SDHA, and SDHB reduced TET1-induced 5hmC levels by 71%, 73%, and 82%, respectively, as compared with control cells coinfected with retrovirus containing the control shRNA vector pMKO.”
- Also stated in: § Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells · plain
“A virtually identical result was obtained for TET2-catalyzed 5hmC production, which was also decreased by 80%, 83% and 69% in cells with stable knockdown of FH, SDHA, and SDHB, respectively.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“At 12-h after siRNA injection, we were able to achieve 62% and 78% reduction of Fh and Sdha mRNA expression, respectively, in mouse livers”
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · plain
“hepatic expression of Fh and Sdha proteins was decreased by threefold and twofold, respectively”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the activity of FH R190H (the most frequent mutation in hereditary leiomyomatosis and renal cell cancer [HLRCC] patients) and FH H137R is only 17% and 10%, respectively, of wild-type FH”
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
“The activity of tumor-derived mutants SDHA G555E and SDHA R554W is 51% and 46%, respectively, of wild-type SDHA, and the activity of SDHB R46Q (the most frequent SDHB mutation in paraganglioma) and SDHB A43P mutants is 48% and 61%, respectively, of wild-type SDHB.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“addition of 2.5 mM methyl-fumarate and 5 mM methyl-succinate to the cultured HeLa cells resulted in a significant increase of intracellular fumarate and succinate, respectively, as determined by gas chromatography-mass spectrometry (GC-MS)”
- Also stated in: § Both fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells · plain
“The fumarate/ a-KG and succinate/a-KG ratios were elevated in these cells”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
- Also stated in: § Both fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Addition of 1 mM, 3 mM, and 10 mM fumarate resulted in >80% inhibition of CeKDM7A”
- Also stated in: § Both fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro · plain
“inhibition of CeKDM7A by fumarate or succinate became less effective, along with increased concentrations of a-KG”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
- Also stated in: § Both fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Transient knockdown of Fh or Sdha by siRNA significantly decreased 5hmC in liver cells, especially near hepatic portal veins”
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · boosted
“a dot blot assay demonstrated that 5hmC production was decreased by 72% and 63% in the livers of Fh and Sdha siRNA knockdown mice, respectively”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cell-permeable fumarate and succinate increased H3K4 monomethylation (by fourfold), H3K27 and H3K79 dimethylation (by fourfold and threefold, respectively), and H3K4 trimethylation (by twofold)”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“depletion of FH and SDHA/B by siRNA resulted in elevated levels of fumarate and succinate in HeLa cells, as determined by GC-MS assay”
- Also stated in: § Fumarate and succinate alter epigenetics · plain
“Knocking down FH and SDHA/B resulted in a significant increase of histone methylations on H3K4, H3K9, and H3K79 (by threefold to fivefold); accumulation of HIF1a (by fivefold); and a decrease of endostatin (by sevenfold)”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Fumarate and succinate alter epigenetics
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Fumarate and succinate alter epigenetics · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“knockdown of FH or SDHA/B resulted in up-regulation of several HOXA genes (e.g., HOXA2, HOXA4, and HOXA5)”
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
“Re-expression of wild-type FH or SDH reduced HOXA gene expression to the control levels.”
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
“In contrast, re-expression of mutant FH or SDH had no effect or even increased HOXA gene expression”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
In the paper
“Transient knockdown of Fh in mouse livers significantly increased monomethylation on H3K4 (by 2.5-fold); dimethylation on H3K9 (by 4.2fold), H3K27 (by 4.3-fold), and H3K79 (by 5.2-fold); and trimethylation on H3K4 (by 2.8-fold).”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
What the sources say
- Not checked yetcites Krivtsov et al. 2008
Tests✗ Asserted: fails✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The authors may not put it forward as true. The paper may give no reason why it holds. It may state two separate claims as one. The quote only partly states this claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Transient knockdown of Fh or Sdha in mouse livers led to accumulation of intracellular fumarate or succinate, respectively, as determined by GC-MS”
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · plain
“Notably, the succinate/a-KG ratio was also elevated in Fh knockdown liver cells, although less dramatically than Sdha knockdown.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tumor-derived FH or SDH mutants are not functional in fumarate or succinate metabolism.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Statistical analysis
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The 5hmC level in most cultured cells is undetectable, but is substantially increased in cells transiently expressing the wild-type catalytic domain of TET1 and TET2 proteins (TET1-CD and TET2-CD)”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells
What the sources say
- Not checked yetcites Tahiliani et al. 2009
- Not checked yetcites Ito et al. 2010
- Not checked yetcites He et al. 2011
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ectopic expression of wild-type FH or SDHA/B resulted in decreases of dimethylation on H3K9 (by 1.5fold) as well as monomethylation and trimethylation on H3K4 (by 2.5-fold and twofold, respectively), consistent with increased KDM activity”
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
“these changes in genome-wide histone methylations were not observed in cells re-expressing tumor-derived FH or SDHA/B mutants”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases
Tests✗ Asserted: fails✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The authors may not put it forward as true. The paper may give no reason why it holds. It may state two separate claims as one. The quote only partly states this claim.
- Also stated in: § Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that cell-permeable fumarate and succinate increased HIF1a and decreased endostatin in both cell types”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate increase genome-wide histone methylations, accumulate HIF1a, and reduce endostatin in cultured cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our results demonstrated that succinate (IC 50 = 0.8 mM) is more potent than fumarate (IC 50 = 1.5 mM) in inhibiting HsKDM4A”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Addition of 5 mM octyl-a-KG diminished the effect of FH or SDHA/B suppression on increasing histone methylations, accumulating HIF1a, and decreasing endostatin”
- Also stated in: § Fumarate and succinate alter epigenetics · plain
“these effects of octyl-a-KG were in a dose-dependent manner”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Fumarate and succinate alter epigenetics
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
- Also stated in: § Fumarate and succinate alter epigenetics · plain
None of the sources cited for this claim have been checked yet.
In the paper
“Thus far, all functionally characterized FH or SDH mutations result in either a complete loss or reduction of enzymatic activity (Tomlinson et al. 2002;Pollard et al. 2005), indicating that both FH and SDH function as tumor suppressors.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Tomlinson et al. 2002
- Not checked yetcites Pollard et al. 2005
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“These mutations in IDH1/2 result in simultaneous loss and gain of activities in the production of a-ketoglutarate (a-KG) and 2-hydroxyglutarate (2-HG), respectively”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Dang et al. 2009
- Not checked yetcites Yan et al. 2009
- Not checked yetcites Zhao et al. 2009
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Of the >60 estimated a-KGdependent dioxygenases in mammalian cells (Rose et al. 2011), the JmjC domain-containing histone demethylases (KDMs) and the TET (ten-eleven translocation) family of DNA hydroxylases play central roles in epigenetic control of genomic information.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Rose et al. 2011
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These enzymes require Fe(II) as a cofactor metal and a-KG as a cosubstrate to catalyze the reactions in which one oxygen atom from molecular oxygen (O 2 ) is attached to a hydroxyl group in the substrate (hydroxylation) while the other is taken up by a-KG, leading to the decarboxylation of a-KG and subsequent release of carbon dioxide (CO 2 ) and succinate.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our study suggests that tumor-derived FH and SDH mutations accumulate fumarate and succinate, leading to enzymatic inhibition of multiple a-KG-dependent dioxygenases and consequent alterations of genome-wide histone and DNA methylation.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“the recently discovered TET family of DNA hydroxylases catalyzes a three-step iterative oxidation reaction: converting 5mC to 5-hydroxymethylcytosine (5hmC), then converting 5hmC to 5-formylcytosine (5fC), and finally converting 5fC to 5-carboxylcytosine (5caC)”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Tahiliani et al. 2009
- Not checked yetcites Ito et al. 2010
- Not checked yetcites He et al. 2011
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“We and others recently demonstrated that ectopic expression of tumor-derived mutated IDH1 and IDH2 inhibits the activity of a-KG-dependent dioxygenases and, more importantly, produces 2-HG, which acts as an antagonist of a-KG to competitively inhibit the activity of a-KG-dependent dioxygenases, including both KDMs and TETs”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Chowdhury et al. 2011
- Not checked yetcites Xu et al. 2011
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies into the mechanism behind how mutations in FH and SDH trigger elevated levels of HIF1a provided evidence that fumarate and succinate accumulated in cells with mutations in either FH or SDH inhibit prolyl hydroxylases (PHDs), which hydroxylates and promotes the degradation of HIF1a”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Abstract
What the sources say
- Not checked yetcites Epstein et al. 2001
- Not checked yetcites Yu et al. 2001
- Not checked yetcites Isaacs et al. 2005
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Given the dependence of TET catalytic activity on a-KG and its inhibition by 2-HG (Xu et al. 2011)”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells
What the sources say
- Not checked yetcites Xu et al. 2011
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, alterations of histone methylation will likely have a broad impact on gene expression, which may also contribute to the tumor suppressor functions of FH and SDH.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Re-expression of wild-type FH and SDH dramatically reduced fumarate and succinate, respectively, in the FH or SDH knockdown cells and thus increased 5hmC by relieving inhibition on TETs.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Tumor-derived FH and SDH mutants inhibit a-KG-dependent dioxygenases
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Taken together, the above findings provide in vivo evidence supporting the notion that decreased activity of FH and SDHA leads to accumulation of fumarate and succinate, which inhibit a-KG-dependent dioxygenases and regulate target gene expression.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Taken together, these data indicate that knockdown of FH and SDHA/B leads to elevated levels of intracellular fumarate and succinate, respectively, which act as competitors of a-KG to inhibit TET-catalyzed hydroxylation of 5mC.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Suppression of FH or SDH expression reduces TET-catalyzed 5hmC production in cultured cells
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These observations suggest that tumor cells containing FH or SDH mutations accumulate fumarate and succinate, which then inhibit histone and DNA demethylations.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Suppression of Fh or Sdha did not significantly affect the hepatic mRNA levels of Tet genes”
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · hedged
“indicating that transient knockdown of Fh or Sdha would inhibit the activity of TETs by not down-regulating the transcription of TET genes.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Knocking down Fh or Sdha inhibits multiple a-KG-dependent dioxygenases and regulates target gene expression in vivo · hedged
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Together, these results suggest that both fumarate and succinate act as antagonists of a-KG to inhibit a-KG- dependent KDMs, with succinate being more potent than fumarate.”
§ Inhibition of a-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors > Both fumarate and succinate inhibit the activity of a-KG-dependent KDMs in vitro
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
TET family enzymes function as tumor suppressors.
“Given the well-characterized tumor suppressor function of TET”
The paper relies on this without support.
Many missense mutations in FH or SDH have unknown functional consequences.
“There are also many missense mutations whose exact functional consequences have not been characterized.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Like D-2HG, fumarate and succinate accumulation can inhibit some αKG-dependent dioxygenases, resulting in hypermethylation of DNA and histones in tumors exhibiting loss of FH or SDH (Hoekstra et al., 2015; Letouze et al., 2013; Xiao et al., 2012).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Xiao et al., 2012
In the citing paper
“Like 2HG accumulation, increased levels of succinate and fumarate can inhibit Jumonji C-domain–containing histone demethylases and TET enzymes, driving a widespread hypermethylation phenotype that disrupts normal cell differentiation (179, 180).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [180]
In the citing paper
“Tumors that exhibit SDH- and FH loss share a number of phenotypic features that are consistent with dioxygenase inhibition, among which is a characteristic global increase in DNA methylation (Killian et al., 2013; Letouze et al., 2013; Xiao et al., 2012), as well as elevated levels of HIF1α (Selak et al., 2005).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Xiao et al., 2012
In the citing paper
“Finally, it was shown that fumarate can drive succination of several members of the family of Iron Sulfur (Fe-S) cluster biogenesis proteins, causing a depletion of Fe-S clusters required for the activity of mitochondrial enzymes, including complex I88.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [88]
In the citing paper
“Succinate inhibits HIF-1␣ signaling through inhibition of PHD2 but can also impact the activity of numerous ␣-ketoglutarate-dependent dioxygenases (42,43).”
From Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels (2016) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
KDM7A substrate is described as both dimethylated and monomethylated
MinorThe assay description calls the H3K9 substrate dimethylated, but the peptide it says was used is monomethylated.
“To measure CeKDM7A demethylase activity toward dimethylated H3K9,”
“synthetic monomethylated peptide corresponding to monomethylated H3K9 (ARTKQTARK (me1)STGGKA) was used as substrate.”
Citations
Cites
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · cited 2×
“Thus far, all functionally characterized FH or SDH mutations result in either a complete loss or reduction of enzymatic activity (Tomlinson et al. 2002; Pollard et al. 2005), indicating that both FH and SDH function as tumor suppressors.”
BackgroundInfluentialIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“…species (ROS) that induce DNA damage and genomic instability (Kaelin 2009), and (3) provoke accumulation of HIF1a, a transcription factor whose stabilization and elevation could promote cell metabolism and angiogenesis (Ivan et al. 2001; Jaakola et al. 2001; Ling et al. 2005; Selak et al. 2005).”
BackgroundSelf-citationCancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · cited 3×
“…mutated IDH1 and IDH2 inhibits the activity of a-KG-dependent dioxygenases and, more importantly, produces 2-HG, which acts as an antagonist of a-KG to competitively inhibit the activity of a-KG-dependent dioxygenases, including both KDMs and TETs (Chowdhury et al. 2011; Xu et al. 2011).”
BackgroundSelf-citationTet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
He, Y., Li, B.-Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. (2011) · Science · doi:10.1126/science.1210944 · Cited by 2,776
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 999
Green, H. L. H., & Brewer, A. C. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00848-y · Cited by 21
Nikam, A. P., Patankar, J. V., Lackner, C., Schöck, E., Kratky, D., Zatloukal, K., & Abuja, P. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066094 · Cited by 20
Advances in Adrenal and Extra-adrenal Paraganglioma: Practical Synopsis for Pathologists
Juhlin, C. C., & Mete, Ö. (2022) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000365 · Cited by 20
Clinical impact of epithelial–mesenchymal transition for cancer therapy
Mukerjee, N., Nag, S., Bhattacharya, B., Alexiou, A. T., Mirgh, D., Mukherjee, D., Adhikari, M. D., Anand, K., Muthusamy, R., Gorai, S., et al. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.260 · Cited by 22
Bernardo‐Castiñeira, C., Valdés, N., Celada, L., Martínez, A. S. J., Sáenz‐de‐Santa‐María, I., Bayón, G. F., Fernández, A. F., Sierra, M., Fraga, M. F., Astudillo, A., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01471 · Cited by 20
Epigenetic Regulators of DNA Cytosine Modification: Promising Targets for Cancer Therapy
Jung, I., An, J., & Ko, M. (2023) · Biomedicines · doi:10.3390/biomedicines11030654 · Cited by 22
Succinate dehydrogenase is essential for epigenetic and metabolic homeostasis in hearts
Li, W., Li, Q., Peng, K., Wang, Y., Wang, X., Chen, Q., Cheng, H., & Ma, Q. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-01015-z · Cited by 21
Basic Mechanisms of Immunometabolites in Shaping the Immune Response
Ryan, D. G., Peace, C. G., & Hooftman, A. (2023) · Journal of Innate Immunity · doi:10.1159/000535452 · Cited by 22
Hu, S., Han, Y., Tan, T.-Y., Chen, H., Gao, J.-W., Wang, L., Yang, M., Zhao, L., Wang, Y., Ding, Y., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.167874 · Cited by 22
SDH defective cancers: molecular mechanisms and treatment strategies
Wang, J., Yuan, T., Yang, B. W., He, Q., & Zhu, H. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10022-w · Cited by 24
Self-citationPérez-Hernández, C. A., Kern, C. C., Butkevičiūtė, E., McCarthy, E., Dockrell, H. M., Moreno‐Altamirano, M. M. B., Aguilar‐López, B. A., Bhosale, G., Wang, H., Gems, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01715 · Cited by 19
Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
Fishbein, L. M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1184-y · Cited by 19
Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
Loras, A., Segovia, C., & Ruiz-Cerdá, J. L. (2021) · Cancers · doi:10.3390/cancers13112719 · Cited by 23
Identification of genomic features in the classification of loss- and gain-of-function mutation
Jung, S., Lee, S., Kim, S., & Nam, H. (2015) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-15-s1-s6 · Cited by 19
Ahmed, A., Iaconisi, G. N., Molfetta, D. D., Coppola, V., Caponio, A., Singh, A., Bibi, A., Capobianco, L., Palmieri, L., Dolce, V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010092 · Cited by 24
Hoekstra, A. S., Addie, R. D., Ras, C., Seifar, R. M., Ruivenkamp, C. A. L., Bruijn, I. H. B., Hes, F. J., Jansen, J. C., Corssmit, E. P. M., Corver, W. E., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw218 · Cited by 19
Targeting the Metabolic Adaptation of Metastatic Cancer
Tarragó‐Celada, J., & Cascante, M. (2021) · Cancers · doi:10.3390/cancers13071641 · Cited by 19
Dynamic multilayered control of m 6 A RNA demethylase activity
Jaafar, C., & Aguiar, R. C. T. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2317847121 · Cited by 24
Chromatin Architecture as an Essential Determinant of Dendritic Cell Function
Boukhaled, G. M., Corrado, M., Guak, H., & Krawczyk, C. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01119 · Cited by 23
Ricketts, C. J., Killian, J. K., Vocke, C. D., Wang, Y., Merino, M. J., Meltzer, P. S., & Linehan, W. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278108 · Cited by 18
Mitochondrial control through nutritionally regulated global histone H3 lysine-4 demethylation
Soloveychik, M., Xu, M., Zaslaver, O., Lee, K., Narula, A., Jiang, R., Rosebrock, A. P., Caudy, A. A., & Meneghini, M. D. (2016) · Scientific Reports · doi:10.1038/srep37942 · Cited by 17
Wang, J., Liu, Y., Hu, J., & Chen, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1109576 · Cited by 24
Self-citationde Bresser, C. J. M., & de Krijger, R. R. (2024) · Endocrine Pathology · doi:10.1007/s12022-024-09830-3 · Cited by 22
Specific regulation of epigenome landscape by metabolic enzymes and metabolites
Yu, X., & Li, S. (2024) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.13049 · Cited by 24
Tumor-suppressive function of SIRT4 in neuroblastoma through mitochondrial damage
Wang, Y., Guo, Y., Gao, J., & Yuan, X. (2018) · Cancer Management and Research · doi:10.2147/cmar.s172509 · Cited by 20
Balnis, J., Drake, L. A., Vincent, C. E., Korponay, T. C., Singer, D. V., Lacomis, D., Lee, C. G., Elias, J. A., Jourd’heuil, D., Singer, H. A., et al. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0551oc · Cited by 19
Genetic screening for monogenic hypertension in hypertensive individuals in a clinical setting
Bao, M., Li, P., Li, Q., Chen, H., Zhong, Y., Li, S., Jin, L., Wang, W., Chen, Z., Zhong, J., et al. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106145 · Cited by 19
Metabolic regulation of regulatory T cells: mechanisms, heterogeneity, and implications in disease
Getachew, F., Hu, J., & Benamar, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1729690 · Cited by 22
Epigenome modifiers and metabolic rewiring: New frontiers in therapeutics
Ferrari, A., Longo, R., Silva, R., Mitro, N., Caruso, D., De Fabiani, E., & Crestani, M. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.008 · Cited by 19
Fumarate integrates metabolism and immunity in diseases
Cheng, J., Xiao, Y., & Jiang, P. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.03.008 · Cited by 25
Touch and go: nuclear proteolysis in the regulation of metabolic genes and cancer
Maneix, L., & Catic, A. (2016) · FEBS Letters · doi:10.1002/1873-3468.12087 · Cited by 17
Hitchler, M. J., & Domann, F. E. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.008 · Cited by 20
Mi, W., Yun, X., Yan, H., Zhang, Y., Cai, X., Zhang, S., He, R., Li, L., Zhu, L., Xia, X., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-02013-z · Cited by 24
Self-citationRetractedEvans, H. M., Schultz, D. F., Boiman, A. J., McKell, M. C., Qualls, J. E., & Deepe, G. S. (2021) · mBio · doi:10.1128/mbio.02710-21 · Cited by 19
Dual Effect of Tryptamine on Prostate Cancer Cell Growth Regulation: A Pilot Study
Li, Z., Ding, B., Ali, M. R. K., Zhao, L., Zang, X., & Lv, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911087 · Cited by 20
Wang, Z., Wang, W., Shi, H., Meng, L., Jiang, X., Pang, S., Fan, M., & Lin, R. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-1575-4 · Cited by 18
Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune ResponsesPreprint
Choi, I., Son, H., & Baek, J.-H. (2020) · Preprints.org · doi:10.20944/preprints202012.0810.v1 · Cited by 19
The nuclear-mitochondrial crosstalk in aging: From mechanisms to therapeutics
Feng, Y., & Lu, Y. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.012 · Cited by 23
Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer
Fan, C., Kam, S., & Ramadori, P. (2021) · Cancers · doi:10.3390/cancers13205250 · Cited by 17
Mitochondria link metabolism and epigenetics in haematopoiesis
Schell, J. C., & Rutter, J. P. (2017) · Nature Cell Biology · doi:10.1038/ncb3540 · Cited by 18
Chang, Y.-L., Hsieh, M., Chang, W., Wang, H., Lin, M., Wang, C., Lou, P., & Teng, S. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5966 · Cited by 17
Silas, Y., Singer, E., Das, K., Lehming, N., & Pines, O. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2026595118 · Cited by 18
Transcriptional regulation of metabolism in disease: From transcription factors to epigenetics
Hawkins, L. J., Al-attar, R., & Storey, K. B. (2018) · PeerJ · doi:10.7717/peerj.5062 · Cited by 17
The Interplay between Dysregulated Metabolism and Epigenetics in Cancer
Bassal, M. A. (2023) · Biomolecules · doi:10.3390/biom13060944 · Cited by 19
Interplay Between Glucose Metabolism and Chromatin Modifications in Cancer
Ma, R., Wu, Y., Li, S., & Yu, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.654337 · Cited by 18
Causes, effects, and clinical implications of perturbed patterns within the cancer epigenome
Oleksiewicz, U., & Machnik, M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.014 · Cited by 18
Unraveling the metabolic‒epigenetic nexus: a new frontier in cardiovascular disease treatment
Ouyang, J., Wu, D.-D., Gan, Y., Tang, Y., Wang, H., & Huang, J. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07525-z · Cited by 21
Zhu, X., Oseghale, A., Nicole, L. H., Li, Y., & Pace, B. S. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219825859 · Cited by 18
Oncometabolic Tracks in the Heart
Taegtmeyer, H., Karlstaedt, A., Rees, M. L., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.310115 · Cited by 18
Sanchez, M., Hamel, D., Bajon, E., Duhamel, F., Bhosle, V. K., Zhu, T., Rivera, J. C., Dabouz, R., Nadeau‐Vallée, M., Sitaras, N., et al. (2022) · Cells · doi:10.3390/cells11142185 · Cited by 18
Mechanical regulation of metabolism, epigenetics, and their interplay
Nam, H., Yu, G., Ahn, S. I., & Nam, S. (2026) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00059-1 · Cited by 25
Alterations of lipid‐mediated mitophagy result in aging‐dependent sensorimotor defects
Oleinik, N., Albayram, O., Kassir, M. F., Atilgan, F. C., Walton, C., Karakaya, E., Kurtz, J., Alekseyenko, A., Alsudani, H., Sheridan, M., et al. (2023) · Aging Cell · doi:10.1111/acel.13954 · Cited by 18
Recent developments in gastroesophageal mesenchymal tumours
Papke, D. J., & Hornick, J. L. (2020) · Histopathology · doi:10.1111/his.14164 · Cited by 19
Proteins moonlighting in tumor metabolism and epigenetics
Lv, L., & Lei, Q. (2021) · Frontiers of Medicine · doi:10.1007/s11684-020-0818-1 · Cited by 18
β-Cell Mitochondrial Dysfunction: Underlying Mechanisms and Potential Therapeutic Strategies
Darwish, R., Alcibahy, Y., Abu-Sharia, G., & Butler, A. E. (2025) · Cells · doi:10.3390/cells14231861 · Cited by 25
Xi, C., Pang, J., Zhi, W., Chang, C., Siddaramappa, U., Shi, H., Horuzsko, A., Pace, B. S., & Zhu, X. (2023) · Blood · doi:10.1182/blood.2022018159 · Cited by 16
Yeast models of mutations in the mitochondrial ATP6 gene found in human cancer cells
Niedźwiecka, K., Kabala, A. M., Lasserre, J.-P., Tribouillard‐Tanvier, D., Golik, P., Dautant, A., di Rago, J., & Kucharczyk, R. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.04.003 · Cited by 18
Włodarczyk, M., Nowicka, G., Ciebiera, M., Ali, M. K., Yang, Q., & Al-Hendy, A. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052720 · Cited by 19
Xiang, K., Kalthoff, C., Münch, C., Jendrossek, V., & Matschke, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05098-9 · Cited by 18
Towards the routine use of in silico screenings for drug discovery using metabolic modelling
Bintener, T., Pacheco, M. P., & Sauter, T. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190867 · Cited by 17
Chatzikyriakou, P., Brempou, D., Quinn, M., Fishbein, L. M., Noberini, R., Anastopoulos, I. N., Tufton, N., Lim, E. S., Obholzer, R., Hubbard, J., et al. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01598-3 · Cited by 23
Kim, H., Lebeau, B., Papadopoli, D. J., Jovanović, P., Russo, M. D. S. T., Avizonis, D. Z., Morita, M., Afzali, F., Ursini‐Siegel, J., Postovit, L.-M. M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109188 · Cited by 17
Mechanisms governing lineage plasticity and metabolic reprogramming in cancer
Perez, L. M., Venugopal, S. V., Martin, A. S., Freedland, S. J., Vizio, D. D., & Freeman, M. R. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.08.001 · Cited by 19
Adhikari, S., Guha, D., Mohan, C., Mukherjee, S., Tyler, J. K., & Das, C. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_1 · Cited by 19
The Redox-Metabolic Couple of T Lymphocytes: Potential Consequences for Hypertension
Moshfegh, C. M., & Case, A. J. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8042 · Cited by 13
Zhang, X., Zhao, J., Yin, X., Liang, J., Wang, Y., Zheng, L., Tan, P., Lin, Y., Xu, N., Zhu, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59513-8 · Cited by 18
Randhawa, J., & Pålsson‐McDermott, E. M. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00461-x · Cited by 21
Bulku, A., Weaver, T. M., & Berkmen, M. B. (2018) · The Open Biochemistry Journal · doi:10.2174/1874091x01812010001 · Cited by 16
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma
Fitzsimmons, C. M., Mandler, M. D., Lunger, J. C., Chan, D., Maligireddy, S. S., Schmiechen, A. C., Gamage, S. T., Link, C. N., Jenkins, L. M. M., Chan, K. C., et al. (2024) · NAR Cancer · doi:10.1093/narcan/zcae004 · Cited by 18
Blanquart, C., Linot, C., Cartron, P., Tomaselli, D., Mai, A., & Bertrand, P. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180706105903 · Cited by 17
TRAP1: A Metabolic Hub Linking Aging Pathophysiology to Mitochondrial S-Nitrosylation
Faienza, F., Rizza, S., Giglio, P., & Filomeni, G. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00340 · Cited by 17
Metabolic orchestration of T lineage differentiation and function
Yong, C. S. M., Moussa, D. A., Cretenet, G., Kinet, S., Dardalhon, V., & Taylor, N. N. (2017) · FEBS Letters · doi:10.1002/1873-3468.12849 · Cited by 16
Epigenetic Therapies in Melanoma—Targeting DNA Methylation and Histone Modification
Țigu, A. B., Ivancuta, A., Uhl, A., Sabo, A. C., Nistor, M., Mureșan, X. M., Cenariu, D., Timis, T., Diculescu, D. M., & Gulei, D. (2025) · Biomedicines · doi:10.3390/biomedicines13051188 · Cited by 17
Prospects of biological and synthetic pharmacotherapies for glioblastoma
Altshuler, D. B., Kadiyala, P., Núñez, F. J., Núñez, F. M., Carney, S. V., Alghamri, M. S., Garcia-Fabiani, M. B., Asad, A. S., Candia, A. J. N., Candolfi, M., et al. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1713085 · Cited by 16
Lin, S., Karoly, E. D., & Taatjes, D. J. (2013) · Aging Cell · doi:10.1111/acel.12108 · Cited by 16
Moonlighting Enzymes at the Interface Between Metabolism and Epigenetics
van der Knaap, J. A., & Verrijzer, C. P. (2025) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-030122-044718 · Cited by 17
Control of topoisomerase II activity and chemotherapeutic inhibition by TCA cycle metabolites
Lee, J. H., Mosher, E. P., Lee, Y., Bumpus, N. N., & Berger, J. M. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.08.014 · Cited by 18
Compartmentation of Metabolites in Regulating Epigenomes of Cancer
Zhao, Z., Wang, L., & Di, L. (2016) · Molecular Medicine · doi:10.2119/molmed.2016.00051 · Cited by 18
Ryder, B., Moore, F., Mitchell, A., Thompson, S. R., Christodoulou, J., & Balasubramaniam, S. (2017) · JIMD Reports · doi:10.1007/8904_2017_65 · Cited by 17
Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
van Gisbergen, M. W., Zwilling, E., & Dubois, L. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653621 · Cited by 20
Metabolites as signalling molecules in the tumour immune microenvironment
Mao, Y., Xia, W., & Jiang, P. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-025-01258-y · Cited by 30
Han, A., Peng, T., Xie, Y., Zhang, W., Sun, W., Xie, Y., Ma, Y., Wang, C., & Xie, N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1301074 · Cited by 15
Tumour metabolites hinder DNA repair
Chen, L., & Xiong, Y. (2020) · Nature · doi:10.1038/d41586-020-01569-1 · Cited by 17
Self-citationHypoxia research, where to now?
Ortmann, B. M., Taylor, C. T., & Rocha, S. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.03.008 · Cited by 18
Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers
Hopp, L., Nersisyan, L., Loeffler‐Wirth, H., Arakelyan, A., & Binder, H. (2015) · Genes · doi:10.3390/genes6041076 · Cited by 16
Boskovic, P., Wilke, N., Man, K.-H., Lichter, P., Francois, L., & Radlwimmer, B. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad190 · Cited by 18
Progress in the Study of Optical Probes for the Detection of Formaldehyde
Xu, X., Yang, E., & Chen, Y. (2022) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2022.2107870 · Cited by 15
Hopp, L., Willscher, E., Loeffler‐Wirth, H., & Binder, H. (2015) · Journal of cancer research updates · doi:10.6000/1929-2279.2015.04.04.1 · Cited by 14
Parkin exerts the tumor‐suppressive effect through targeting mitochondria
Sun, X., Ye, G., Mai, Y., Shu, Y., Wang, L., & Zhang, J. (2023) · Medicinal Research Reviews · doi:10.1002/med.21938 · Cited by 17
Novel Hereditary Forms of Pheochromocytomas and Paragangliomas
Dahia, P. L. M. (2013) · Frontiers of hormone research · doi:10.1159/000345671 · Cited by 16
SIRT4 protects against intestinal fibrosis by facilitating GLS1 degradation
Xue, X., Zeng, X., Wu, X., Mu, K., Dai, Y., & Wei, Z. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.08.001 · Cited by 16
Zhang, T., Chen, L., Guo, X., Li, S., He, X., Pei, S., & Li, D. (2022) · Food & Function · doi:10.1039/d1fo04420f · Cited by 17
Pei, S., Zhao, H., Chen, L., He, X., Hua, Q., Meng, X., Shi, R., Zhang, J., Zhang, H., Liu, R., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07574 · Cited by 17
Lipid metabolism in B cell biology
Peeters, R., & Jellusova, J. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13560 · Cited by 15
Metabolomics in paraganglioma: applications and perspectives from genetics to therapy
Richter, S., Garrett, T. J., Bechmann, N., Clifton-Bligh, R. J., & Ghayee, H. K. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0376 · Cited by 16
Methyl Group Metabolism in Differentiation, Aging, and Cancer
Erichsen, L., Thimm, C., & Santourlidis, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158378 · Cited by 15
Model systems in SDHx-related pheochromocytoma/paraganglioma
Takács‐Vellai, K., Farkas, Z., Ősz, F., & Stewart, G. W. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10009-z · Cited by 16
Garimella, S. V., Gampa, S. C., & Chaturvedi, P. (2023) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s417842 · Cited by 16
Argininosuccinate lyase drives activation of mutant TERT promoter in glioblastomas
Shi, Z., Ge, X. Q., Li, M., Yin, J., Wang, X., Zhang, J., Chen, D., Li, X., Wang, X., Ji, J., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.09.024 · Cited by 16
Role of oxygen sensing and hypoxia-inducible factors in orchestrating innate immune responses
Low, J. T., Kim, Y., Matsushita, M., & Ho, P. (2025) · Nature Immunology · doi:10.1038/s41590-025-02317-1 · Cited by 18
Metadata
- Authors
- Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., Zhao, S., Ye, D., Xiong, Y., & Guan, K.-L.
- Affiliations
- Fudan University (CN)
- Shanghai Medical College of Fudan University (CN)
- Chinese Academy of Sciences (CN)
- University of North Carolina at Chapel Hill (US)
- ORCID
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-06-07
- Volume
- 26
- Issue
- 12
- Pages
- 1326-1338
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC3387660
- OpenAlex
- W2104852749
- Semantic Scholar
- 0692bd51f83e69f21dab4f3e869a55299d72df6b
- Cited by
- 1,188
- References
- 50
- Citations by year
- 2026: 141 · 2025: 96 · 2024: 85 · 2023: 100 · 2022: 99 · 2021: 96 · 2020: 105 · 2019: 91 · 2018: 70 · 2017: 84 · 2016: 74 · 2015: 54 · 2014: 50 · 2013: 33 · 2012: 9
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- James S. McDonnell Foundation
- Samuel Waxman Cancer Research Foundation
- National Natural Science Foundation of China (2012CB910101, 2012CB910300, 30600112, 31071192, 81120108016, 30871255)
- National Institutes of Health
- Shanghai Leading Academic Discipline Project
- National Cancer Institute (F31CA260794)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- fumarate hydratase, succinate dehydrogenase, fumarate, succinic acid, alpha-ketoglutarate-dependent dioxygenase, histone demethylase, DNA demethylase, prolyl hydroxylase, collagen prolyl 4-hydroxylase, competitive inhibition, tumor suppressor mutations, epigenetic modifications, DNA methylation, histone methylation, TCA cycle, carcinogenesis
- MeSH terms
- Animals, Cells, Cultured, Fumarate Hydratase, Fumarates, Gene Expression Regulation, Humans, Ketoglutaric Acids, Models, Biological, Mutation, Succinate Dehydrogenase, Genome, Human, DNA Methylation, Succinic Acid, Tumor Suppressor Proteins, Endostatins, Dioxygenases, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Biocatalysis, Gene Knockdown Techniques, Histone Demethylases, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
